CANSINO BIOLOGICS IN

6185

End-of-day quote - 09/24
280.2HKD	-0.64%

Prev.	282.0000
Open	282.0000
High	289.4000
Low	277.2000
Volume	593 772

2d ago	CanSino Biologics : CanSinoBIO's COVID vaccine, tested at lower dosage, safe...
6d ago	CanSino Biologics Inc.(XSSC:688185) added to S&P Global BMI Index
09/10	Cansino Biologics Inc. Announces Executive Changes
09/07	CanSino Biologics : Indonesia approves J&J, Cansino COVID-19 vaccines for...

	Short Term	Mid-Term	Long Term
Trend	Bearish	Neutral	Bullish
Resistance	289	422	422
Spread/Res.	-3,1%	-34%	-34%
Spread/Supp.	7,5%	7,5%	11%
Support	261	261	252

Sales 2021	9 984 M 1 544 M 1 544 M
Net income 2021	5 282 M 817 M 817 M
Net cash 2021	5 073 M 785 M 785 M
P/E ratio 2021	11,6x
Yield 2021	0,00%

Capitalization	38 163 M 5 902 M 5 902 M
EV / Sales 2021	3,31x
EV / Sales 2022	0,88x
Nbr of Employees	726
Free-Float	37,1%

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more

Sector :

Biopharmaceuticals

Calendar :

No events available

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	BUY
Number of Analysts	8
Last Close Price	232,71 CNY
Average target price	308,77 CNY
Spread / Average Target	32,7%